Molecular Genotyping in Brazilian Patients with the Classical and Nonclassical Forms of 21-hydroxylase Deficiency
Overview
Authors
Affiliations
The aim of our study was to determine, by allele-specific PCR, the frequency of point mutations in 130 Brazilian patients with the classical and nonclassical forms of 21-hydroxylase deficiency and to correlate genotype with phenotype. The most frequent mutations were 12 splice (41.8% in salt wasting), I172N (32.6% in simple virilizing), and V281L (40.2% in late onset form). The frequency of the 9 most common point mutations was similar to that reported for other countries, except for Del 8 nt and Cluster, which were less frequent in the classical form. Rarer mutations such as P453S, G291S, I7 splice, W405X, R483P, and R483-->frameshift were rarely found or were absent. The 93 fully genotyped patients were classified into 3 mutation groups, based on the degree of enzymatic activity (group A, <2%; group B, approximately 2%, and group C, >18%). In group A, 62% of the cases presented the salt wasting form; in group B, 96% the simple virilizing form; and in group C, 88% the late onset form. We diagnosed 80% of the affected alleles after screening for large rearrangements and 15 point mutations. The absence of previously described mutations in 20% of the affected alleles suggests the presence of new mutations in our population.
CONGENITAL ADRENAL HYPERPLASIA WITH COMPOUND HETEROZYGOUS I2 SPLICE AND P453S MUTATIONS.
Almacan B, Ozdemir N, Onay H, Hekimsoy Z Acta Endocrinol (Buchar). 2022; 18(2):228-231.
PMID: 36212252 PMC: 9512366. DOI: 10.4183/aeb.2022.228.
Weber J, Tanawattanacharoen V, Seagroves A, Liang M, Koppin C, Ross H J Clin Endocrinol Metab. 2021; 107(1):e264-e271.
PMID: 34397083 PMC: 8826013. DOI: 10.1210/clinem/dgab600.
Adrenal crisis and mortality rate in adrenal insufficiency and congenital adrenal hyperplasia.
Lousada L, Mendonca B, Bachega T Arch Endocrinol Metab. 2021; 65(4):488-494.
PMID: 34283908 PMC: 10522175. DOI: 10.20945/2359-3997000000392.
Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.
Claahsen-van der Grinten H, Speiser P, Ahmed S, Arlt W, Auchus R, Falhammar H Endocr Rev. 2021; 43(1):91-159.
PMID: 33961029 PMC: 8755999. DOI: 10.1210/endrev/bnab016.
Kocova M, Anastasovska V, Falhammar H Endocrine. 2020; 69(2):262-277.
PMID: 32367336 PMC: 7392929. DOI: 10.1007/s12020-020-02323-3.